- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory High Grade B-Cell Lymphoma in Australia
Total 327 results
-
Peter MacCallum Cancer Centre, AustraliaHoffmann-La RocheActive, not recruitingDiffuse Large B Cell Lymphoma | High-grade B-cell LymphomaAustralia
-
Hoffmann-La RocheCompletedDiffuse Large B-cell Lymphoma | High-Grade B-cell LymphomaUnited States, Spain, Australia, Denmark
-
BeiGeneRecruitingRefractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Relapsed Follicular Lymphoma | Refractory Small Lymphocytic Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Refractory Diffuse Large B-cell Lymphoma | Transformed Non-Hodgkin Lymphoma | Relapsed... and other conditionsChina, Australia
-
AstraZenecaRecruitingFollicular Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | B-cell Non Hodgkin LymphomaKorea, Republic of, United States, Japan, Taiwan, Australia
-
GenmabAbbVieActive, not recruitingSmall Lymphocytic Lymphoma (SLL) | DLBCL | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | MCL | Marginal Zone Lymphoma (MZL) | High-grade B-cell Lymphoma (HGBCL) | FLKorea, Republic of, United States, Australia, Singapore, Netherlands, Sweden, France, Finland, United Kingdom, Spain, Germany, Denmark, Italy, Poland, Canada
-
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)RecruitingFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | MALT Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Indolent Lymphoma | Refractory B-Cell LymphomaUnited States, Australia, China
-
AmgenMerck Sharp & Dohme LLCCompletedRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)United States, Germany, Spain, Australia, Netherlands, France
-
Allogene TherapeuticsRecruitingRelapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic LymphomaUnited States, Spain, Canada, Australia, Italy
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Large B-cell LymphomaUnited States, Australia, Canada
-
Iksuda Therapeutics Ltd.RecruitingFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non-Hodgkin LymphomaAustralia, Canada, United States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Lymphoproliferative Disorder | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Grade 3 Follicular... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)Merck Sharp & Dohme LLCRecruitingRelapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell LymphomaAustralia, Spain, United States, France, Hungary, New Zealand, Poland, Serbia, Canada, Romania
-
BeiGeneRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Advanced Solid Tumor | Diffuse Large B Cell Lymphoma | Small Lymphocytic LymphomaAustralia, China
-
Janssen Research & Development, LLCCity of Hope Medical CenterRecruitingRelapsed or Refractory B Cell Non-Hodgkin LymphomaUnited States, Australia
-
Genentech, Inc.CompletedLymphocytic Leukemia, Chronic, Diffuse Large B-Cell LymphomaUnited States, Australia
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)United States, Spain, United Kingdom, Canada, Netherlands, Germany, France, Sweden, Israel, Switzerland, Belgium, Australia, Austria, Italy
-
Janssen Research & Development, LLCMayo ClinicRecruitingRelapsed or Refractory B Cell Non-Hodgkin LymphomaUnited States, Australia, Israel
-
Arbeitsgemeinschaft medikamentoese TumortherapieHoffmann-La RocheCompletedDiffuse Large B-Cell Lymphoma (DLBCL) | Follicular NHL Grade 3bHong Kong, Thailand, Sweden, Taiwan, Mexico, Austria, Serbia, China, Czech Republic, Australia, Malaysia, Croatia, Israel, South Africa, Bosnia and Herzegovina, Brazil, Bulgaria, Estonia, Latvia, Macedonia, The Former Yugoslav... and more
-
Caribou Biosciences, Inc.RecruitingLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | B Cell Non-Hodgkin's LymphomaUnited States, Australia, Israel
-
Allogene TherapeuticsRecruitingRelapsed/Refractory Large B Cell LymphomaBelgium, United States, Austria
-
Kite, A Gilead CompanyRecruitingHigh-risk Large B-cell Lymphoma (LBCL)United States, Austria, Spain, Italy, Australia, Germany, Netherlands, Canada, Portugal, United Kingdom, France
-
GWT-TUD GmbHHoffmann-La RocheRecruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-cell LymphomaGermany, Spain, United Kingdom, Austria
-
TG Therapeutics, Inc.Completed
-
Austin HealthAstraZeneca; Olivia Newton-John Cancer Research InstituteCompletedFollicular Lymphoma | Diffuse Large B Cell LymphomaAustralia
-
Austin HealthMerck KGaA, Darmstadt, GermanyActive, not recruitingLymphomas Non-Hodgkin's B-CellAustralia
-
Karyopharm Therapeutics IncRecruitingRelapsed/Refractory Diffuse Large B-cell LymphomaUnited States, Spain, Israel, Italy, Poland, China, Austria
-
AmgenTerminatedHigh-risk Diffuse Large B-cell LymphomaUnited States, Italy, Belgium, Switzerland, Australia, France, Greece
-
AbbVieRecruitingFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Chronic Lymphocytic LeukemiaUnited States, Australia, Canada, Israel
-
Fondazione Italiana Linfomi - ETSActive, not recruitingIndolent B-Cell LymphomasFrance, Italy, Brazil, Austria, Portugal, Ukraine
-
Novartis PharmaceuticalsRecruitingAcute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Small Lymphocytic Lymphoma | Large B-cell LymphomaJapan, Australia, Germany, Italy, Spain, France, Austria, United States
-
Arbeitsgemeinschaft medikamentoese TumortherapieHoffmann-La Roche; LipomedCompletedLymphoma of Mucosa-Associated Lymphoid TissueAustria
-
Kartos Therapeutics, Inc.RecruitingChronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaBelgium, Korea, Republic of, United States, United Kingdom, Italy, Switzerland, Australia, France, Poland, Portugal, Czechia
-
Dizal PharmaceuticalsNot yet recruitingLymphoma, Non-HodgkinAustralia
-
CTI BioPharmaCompletedDiffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 LymphomaUnited States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
-
Peter MacCallum Cancer Centre, AustraliaGlaxoSmithKline; Merck Sharp & Dohme LLCTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone LymphomaAustralia
-
Epizyme, Inc.CompletedB-cell Lymphomas (Phase 1) | Advanced Solid Tumors (Phase 1) | Diffuse Large B-cell Lymphoma (Phase 2) | Follicular Lymphoma (Phase 2) | Transformed Follicular Lymphoma | Primary Mediastinal Large B-Cell LymphomaAustralia, Canada, France, Germany, Italy, Poland, Taiwan, Ukraine, United Kingdom, United States
-
Hoffmann-La RocheCompletedDiffuse Large B-Cell Lymphoma, Lymphoma FollicularUnited States, Australia, Italy
-
TG Therapeutics, Inc.TerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic LymphomaUnited States, Poland, Australia, Italy, United Kingdom, Israel, Korea, Republic of, Slovakia, Spain
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Non-Hodgkin Lymphoma | Relapsed or Refractory Chronic Lymphocytic LeukemiaUnited Kingdom, Spain, France, Australia
-
Haisco Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory B-Cell MalignanciesChina, Australia
-
Novartis PharmaceuticalsAvailableAcute Lymphoblastic Leukemia (ALL) | Diffuse Large B-cell Lymphoma (DLBCL)United States, Canada, Australia
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedRelapsed or Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Austria, Belgium, France, Ireland, Italy, Poland, Spain, United Kingdom
-
International Extranodal Lymphoma Study Group (IELSG)CompletedMarginal Zone B-cell LymphomaItaly, Switzerland, Austria
-
Australasian Leukaemia and Lymphoma GroupRecruitingMantle Cell Lymphoma | Mantle Cell Lymphoma RefractoryAustralia
-
Hoffmann-La RocheTerminatedLymphoma, Large B-Cell, Diffuse | Follicular LymphomaUnited States, Australia, Germany, Korea, Republic of, New Zealand
-
Dren BioNovotech (Australia) Pty LimitedRecruitingB-cell Non Hodgkin LymphomaAustralia, Hong Kong, Korea, Republic of, Singapore, Taiwan
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell LymphomaAustria, Canada, United States
-
AbbVieRecruitingDiffuse Large B-Cell Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | B Cell MalignanciesUnited States, Israel, Australia, France, United Kingdom, Belgium, Spain
-
Hoffmann-La RocheTerminatedNon-Hodgkin's LymphomaUnited States, Australia, Korea, Republic of, Germany, New Zealand